{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:42:30Z","timestamp":1790991750083,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00415-021-10421-z","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T09:03:12Z","timestamp":1611997392000},"page":"2466-2472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effects of immunotherapies and clinical outcomes in neurosarcoidosis: a retrospective cohort study"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5024-3615","authenticated-orcid":false,"given":"Tarunya","family":"Arun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,30]]},"reference":[{"issue":"16","key":"10421_CR1","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/archinte.1997.00440370104011","volume":"157","author":"EE Lower","year":"1997","unstructured":"Lower EE, Broderick JP, Brott TG, Baughman RP (1997) Diagnosis and management of neurological sarcoidosis. Arch Intern Med 157(16):1864\u20131868","journal-title":"Arch Intern Med"},{"issue":"3","key":"10421_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/WCO.0000000000000684","volume":"32","author":"M Voortman","year":"2019","unstructured":"Voortman M, Drent M, Baughman RP (2019) Management of neurosarcoidosis: a clinical challenge. Curr Opin Neurol 32(3):475\u2013483","journal-title":"Curr Opin Neurol"},{"key":"10421_CR3","first-page":"27","volume":"10","author":"AE Gamal","year":"2018","unstructured":"Gamal AE (2018) Sarcoidosis - symptoms, diagnosis and treatment: treatment algorithm. BMJ Best Practice 10:27\u201345","journal-title":"BMJ Best Practice"},{"issue":"5","key":"10421_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/MCP.0b013e3283642a7a","volume":"19","author":"JP Cremers","year":"2013","unstructured":"Cremers JP, Drent M, Bast A, Shigemitsu H, Baughman RP, Valeyre D et al (2013) Multinational evidence-based world association of sarcoidosis and other granulomatous disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med 19(5):545\u2013561","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10421_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1378\/chest.12-1728","volume":"144","author":"ADM Vorselaars","year":"2013","unstructured":"Vorselaars ADM, Wuyts WA, Vorselaars VMM, Zanen P, Deneer VHM, Veltkamp M et al (2013) Methotrexate vs. azathioprine in second-line therapy of sarcoidosis. Chest 144(3):805\u2013812","journal-title":"Chest"},{"issue":"24","key":"10421_CR6","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1212\/WNL.0000000000003431","volume":"87","author":"S Bitoun","year":"2016","unstructured":"Bitoun S, Bouvry D, Borie R, Mahevas M, Sacre K, Haroche J et al (2016) Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil. Neurology 87(24):2517\u20132521","journal-title":"Neurology"},{"issue":"7","key":"10421_CR7","first-page":"325","volume":"12","author":"SH Beegle","year":"2013","unstructured":"Beegle SH, Barba K, Gobunsuy R, Judson MA (2013) Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Design Develop Thera 12(7):325\u2013338","journal-title":"Drug Design Develop Thera"},{"key":"10421_CR8","first-page":"100004","volume":"1","author":"M Sharp","year":"2019","unstructured":"Sharp M, Donnelly SC, Moller DR (2019) Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents. Respir Med X 1:100004","journal-title":"Respir Med X"},{"issue":"4","key":"10421_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11940-013-0242-9","volume":"15","author":"K Nozaki","year":"2013","unstructured":"Nozaki K, Judson MA (2013) Neurosarcoidosis. Curr Treat Options Neurol 15(4):492\u2013504","journal-title":"Curr Treat Options Neurol"},{"issue":"3","key":"10421_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1183\/09031936.06.00105805","volume":"28","author":"JC Grutters","year":"2006","unstructured":"Grutters JC, van den Bosch JM (2006) Corticosteroid treatment in sarcoidosis. Euro Resp J 28(3):627\u2013636","journal-title":"Euro Resp J"},{"key":"10421_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/MCP.0000000000000401","volume":"23","author":"D Fritz","year":"2017","unstructured":"Fritz D, Voortman M, van de Beek D et al (2017) Many faces of neurosarcoidosis: from chronic meningitis to myelopathy. Curr Opin Pulm Med 23:439\u2013446","journal-title":"Curr Opin Pulm Med"},{"key":"10421_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12883-016-0741-x","volume":"16","author":"D Fritz","year":"2016","unstructured":"Fritz D, van de Beek D, Brouwer M (2016) Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol 16:220","journal-title":"BMC Neurol"},{"issue":"7","key":"10421_CR13","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1161\/STROKEAHA.117.017866","volume":"48","author":"JP Broderick","year":"2017","unstructured":"Broderick JP, Adeoye O, Elm J (2017) Evolution of the modified Rankin scale and its use in future stroke trials. Stroke 48(7):2007\u20132012","journal-title":"Stroke"},{"issue":"16 Suppl 1","key":"10421_CR14","first-page":"10","volume":"88","author":"M Affan","year":"2017","unstructured":"Affan M, Kananeh M, Schultz L, Elias S, Cerghet M (2017) Disease course and treatment of neurosarcoidosis in a single center cohort study of 113 cases. Neurology 88(16 Suppl 1):10","journal-title":"Neurology"},{"key":"10421_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00415-017-8444-9","volume":"264","author":"F Cohen Aubart","year":"2017","unstructured":"Cohen Aubart F, Bouvry D, Galanaud D et al (2017) Long-term outcomes of refractory neurosarcoidosis treated with infliximab. J Neurol 264:891\u2013897","journal-title":"J Neurol"},{"key":"10421_CR16","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","volume":"89","author":"JM Gelfand","year":"2017","unstructured":"Gelfand JM, Bradshaw MJ, Stern BJ et al (2017) Infliximab for the treatment of CNS sarcoidosis: a multiinstitutional series. Neurology 89:2092\u20132100","journal-title":"Neurology"},{"key":"10421_CR17","first-page":"1212","volume":"10","author":"T Arun","year":"2020","unstructured":"Arun T, Pattison L, Palace J (2020) Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: a retrospective cohort study. Neurology 10:1212","journal-title":"Neurology"},{"issue":"2","key":"10421_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.36648\/2171-6625.10.2.292","volume":"10","author":"M Voortman","year":"2019","unstructured":"Voortman M, Fritz D, Vogels OJM, Beek DVD, Vries JD, Brouwer MC et al (2019) Clinical Manifestations of Neurosarcoidosis in the Netherlands. J Neurol Neurosci 10(2):292","journal-title":"J Neurol Neurosci"},{"key":"10421_CR19","first-page":"236905","volume":"24","author":"AD Birnbaum","year":"2014","unstructured":"Birnbaum AD, Rifkin LM (2014) Sarcoidosis: sex-dependent variations in presentation and management. J Ophthalmol 24:236905","journal-title":"J Ophthalmol"},{"issue":"5","key":"10421_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/archneur.64.5.691","volume":"64","author":"TF Scott","year":"2007","unstructured":"Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C (2007) Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol 64(5):691\u2013696","journal-title":"Arch Neurol"},{"issue":"4","key":"10421_CR21","doi-asserted-by":"publisher","first-page":"e743","DOI":"10.1212\/NXI.0000000000000743","volume":"7","author":"J Lord","year":"2020","unstructured":"Lord J, Soldan M et al (2020) Neurosarcoidosis: Longitudinal experience in a single-centre, academic healthcare system. Neurol Neuroimmunol Neuroinflamm 7(4):e743","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10421_CR22","doi-asserted-by":"publisher","first-page":"105811","DOI":"10.1016\/j.clineuro.2020.105811","volume":"194","author":"DP Kidd","year":"2020","unstructured":"Kidd DP (2020) Sarcoidosis of the central nervous system: Safety and efficacy of treatment, and experience of biological therapies. Clin Neurol Neurosurg 194:105811","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10421-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10421-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10421-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T15:11:48Z","timestamp":1624288308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10421-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10421"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10421-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]},"assertion":[{"value":"16 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}